Schrodinger Inc
SDGR19.505USD
+0.475+2.50%
交易中 （美东）报价延迟15分钟
1.44B总市值
亏损市盈率 TTM
关于 Schrodinger Inc 公司
Schrodinger, Inc. 运营一个基于物理的计算平台，该平台能够发现用于药物开发和材料应用的分子。该软件平台被世界各地的生物制药和工业公司、学术机构和政府实验室使用。该公司通过两个部门运营：软件和药物发现。软件部门专注于销售其软件，以改变整个生命科学行业以及材料科学行业的药物发现。药物发现部门专注于通过内部和合作建立多样化的临床前和临床项目组合，这些项目已进入发现和开发的各个阶段。该公司的药物发现项目包括 SGR-1505（MALT1 抑制剂）、SGR-2921（CDC7 抑制剂）、SGR-3515（WEE1 抑制剂）。其软件被全球 1,760 多家学术机构的研究人员使用。
公司简介
公司代码SDGR
公司名称Schrodinger Inc
上市日期Feb 06, 2020
CEODr. Ramy Farid, Ph.D.
员工数量891
证券类型Ordinary Share
年结日Feb 06
公司地址1540 Broadway
城市NEW YORK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编10036
电话15032991150
网址https://www.schrodinger.com
公司代码SDGR
上市日期Feb 06, 2020
CEODr. Ramy Farid, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.24M
+0.49%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
36.99K
-30.96%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
25.97K
+92.81%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
23.64K
+112.26%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
12.25K
+95.95%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
12.25K
+95.95%
Michael M. Lynton ,
Michael M. Lynton ,
Independent Chairman of the Board
Independent Chairman of the Board
12.25K
+95.95%
Ms. Bridget Anne Van Kralingen
Ms. Bridget Anne Van Kralingen
Independent Director
Independent Director
11.50K
+14.99%
Mr. Mannix Aklian
Mr. Mannix Aklian
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing
--
--
Mr. Gary Ginsberg, J.D.
Mr. Gary Ginsberg, J.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.24M
+0.49%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
36.99K
-30.96%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
25.97K
+92.81%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
23.64K
+112.26%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
12.25K
+95.95%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
12.25K
+95.95%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
On-premise software
25.42M
42.69%
Hosted software
10.87M
18.26%
Drug discovery services
10.24M
17.19%
Software maintenance
6.80M
11.41%
Contribution
3.84M
6.45%
其他
2.38M
4.00%
地区USD
名称
营收
占比
United States
29.66M
49.81%
EMEA
23.08M
38.76%
APAC
6.07M
10.20%
Rest of World
731.00K
1.23%
业务
地区
业务USD
名称
营收
占比
On-premise software
25.42M
42.69%
Hosted software
10.87M
18.26%
Drug discovery services
10.24M
17.19%
Software maintenance
6.80M
11.41%
Contribution
3.84M
6.45%
其他
2.38M
4.00%
股东统计
更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
12.68%
Bill & Melinda Gates Foundation Trust
10.83%
The Vanguard Group, Inc.
10.25%
Rubric Capital Management LP
7.76%
Amova Asset Management Co., Ltd.
5.66%
其他
52.82%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
12.68%
Bill & Melinda Gates Foundation Trust
10.83%
The Vanguard Group, Inc.
10.25%
Rubric Capital Management LP
7.76%
Amova Asset Management Co., Ltd.
5.66%
其他
52.82%
股东类型
持股股东
占比
Investment Advisor
47.98%
Investment Advisor/Hedge Fund
24.66%
Hedge Fund
19.47%
Endowment Fund
10.83%
Individual Investor
2.65%
Research Firm
2.47%
Bank and Trust
1.73%
Pension Fund
0.89%
Venture Capital
0.07%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
572
66.46M
103.14%
-5.60M
2025Q1
593
67.21M
104.69%
-5.43M
2024Q4
576
64.44M
100.89%
-9.04M
2024Q3
581
67.44M
105.91%
-6.15M
2024Q2
573
64.76M
101.80%
-8.12M
2024Q1
574
63.48M
100.05%
-5.40M
2023Q4
584
62.06M
98.56%
-7.64M
2023Q3
586
63.62M
101.35%
-15.42M
2023Q2
584
64.04M
102.20%
-7.30M
2023Q1
543
57.09M
91.59%
-11.19M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.75M
12.07%
-354.21K
-4.37%
Mar 31, 2025
Bill & Melinda Gates Foundation Trust
6.98M
10.87%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
6.53M
10.17%
-72.09K
-1.09%
Mar 31, 2025
Rubric Capital Management LP
4.80M
7.48%
-200.00K
-4.00%
Mar 31, 2025
Amova Asset Management Co., Ltd.
3.46M
5.39%
-48.10K
-1.37%
Mar 31, 2025
Cadian Capital Management LP
1.10M
1.72%
+1.10M
--
Mar 31, 2025
Stephens Investment Management Group, LLC
1.97M
3.07%
+362.29K
+22.53%
Mar 31, 2025
State Street Global Advisors (US)
2.21M
3.44%
-104.66K
-4.52%
Mar 31, 2025
ARK Investment Management LLC
2.29M
3.57%
+85.76K
+3.88%
Mar 31, 2025
UBS Asset Management (Americas) LLC
1.81M
2.82%
+1.81M
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
